Fludarabine AUC and outcomes following Axi-cel in aggressive B-NHL

09.12.23

Fludarabine AUC and outcomes following Axi-cel in aggressive B-NHL

by ASTCT Science Highlights

Axi-cel outcome in treatment for R/R large B-cell lymphoma

08.01.23

Axi-cel outcome in treatment for R/R large B-cell lymphoma

by ASTCT Science Highlights

Human DPTs directly involved in GVHD pathogenesis

07.06.23

Human DPTs directly involved in GVHD pathogenesis

by ASTCT Science Highlights

Motixafortide + G-CSF boosts CD34+ HSPCs in MM patients for ASCT

07.03.23

Motixafortide + G-CSF boosts CD34+ HSPCs in MM patients for ASCT

by ASTCT Science Highlights

Brentuximab vedotin consolidation post-ASCT in children with R/R HL

05.18.23

Brentuximab vedotin consolidation post-ASCT in children with R/R HL

by ASTCT Science Highlights

Multi-hit TP53MT impact on transplant outcome in myelofibrosis

05.16.23

Multi-hit TP53MT impact on transplant outcome in myelofibrosis

by ASTCT Science Highlights

Sequence variation in NKG2D, MICA, and MICB affect risk of relapse post-HCT

04.25.23

Sequence variation in NKG2D, MICA, and MICB affect risk of relapse post-HCT

by ASTCT Science Highlights

Letermovir prophylaxis against CMV after HCT

03.13.23

Letermovir prophylaxis against CMV after HCT

by ASTCT Science Highlights

Combining TIGIT inhibition with immunomodulary drugs may prevent MM progression after SCT

03.09.23

Combining TIGIT inhibition with immunomodulary drugs may prevent MM progression after SCT

by ASTCT Science Highlights

Theme picker